Fundraising Fox
/People
Sign in

Curt Herberts

Investor

Investor at Premji Invest · Board director at Kriya Therapeutics

Menlo Park, California, United States

Find your path to Curt

979 people in our graph share verified history with Curt — schools, employers, funds. One of them is your warm intro.

Andrew LeeunlockedCurt: together at Sangamo Therapeutics (2010)
Curt: together at Senti Biosciences
×10Curt: together at Pear VC

About

Curt Herberts has over 20 years of experience in operations, corporate development, and strategy at cell and gene therapy companies. He was President and COO at Kriya Therapeutics, and previously held CFO, CBO, and COO roles at Senti Biosciences and Chief Business Officer at Sangamo Therapeutics, along with consulting work at Campbell Alliance Group. He holds a B.A. in Human Biology from Stanford University and a Master of Business and Science from the Keck Graduate Institute of Applied Life Sciences.

Likely email· guessed from name + firm domain, not firm-published

Invests in

Biotech

Board director at Kriya Therapeutics

Intro paths

→

In turn, Curt can intro founders to Kriya Therapeutics's investors below.

Kriya Therapeutics's investors · 9

Alumni VenturesManchester · $100K – $10M checks · since 2025Amplo VenturesHouston · since 2021Bluebird VenturesPalo Alto · since 2021Foresite CapitalWest Hollywood · since 2021Holland CapitalAmsterdam · since 2021JDRF T1D FundBoston · since 2021Narya CapitalColumbus · since 2021Patient Square CapitalMenlo Park · since 2021Premji InvestMenlo Park · since 2021

Co-founders at Kriya Therapeutics

SRShankar Ramaswamy
Shankar RamaswamyCo-Founder, Chairman & CEO
RJRoger Jeffs
Roger JeffsCo-Founder & Vice Chairman
FWFraser Wright
Fraser WrightScientific Co-Founder & Chief Gene Therapy Officer
SRShankar Ramaswamy, M.D.
Shankar Ramaswamy, M.D.Founder

Experience

  1. Premji Invest - USPremji Invest CXO Advisor Boardcurrent2026 — present
  2. Pear VCPear VC Advisor Councilcurrent2023 — present
  3. Kriya Therapeutics, Inc.President & Chief Operating Officer2022 — 2025
  4. Senti BiosciencesChief Operating Officer2021 — 2022
  5. Senti BiosciencesCFO and CBO2018 — 2020
  6. Sangamo Therapeutics, Inc.Chief Business Officer2010 — 2018
  7. inVentiv Health - Campbell Alliance, Management ConsultingSenior Practice Executive2006 — 2010
  8. CaltechTechnology Transfer2005 — 2006
  9. Amylin PharmaceuticalsNew Product Strategy2005 — 2006
  10. Neurocrine BiosciencesNew Product Strategy2005

Skills & more

Global Business Development12Management Consulting28Marketing6Business Development16Brand Management1Biotechnology18

From Curt's professional profile.

Colleagues at Premji Invest

Adrienne Coulson
Investor at Premji Invest
Aidan Pak
Investor at Premji Invest
Akshay Kini
Investor at Premji Invest
Alex Zhang
Investor at Premji Invest
Amy Covey
Investor at Premji Invest
Ana Mendy
Investor at Premji Invest
Brad Arkin
Investor at Premji Invest
Ed Anuff
Investor at Premji Invest

Frequently asked questions

Who is Curt Herberts?
Curt Herberts has over 20 years of experience in operations, corporate development, and strategy at cell and gene therapy companies. He was President and COO at Kriya Therapeutics, and previously held CFO, CBO, and COO roles at Senti Biosciences and Chief Business Officer at Sangamo Therapeutics, along with consulting work at Campbell Alliance Group. He holds a B.A. in Human Biology from Stanford University and a Master of Business and Science from the Keck Graduate Institute of Applied Life Sciences.
Where does Curt Herberts work?
Curt Herberts is at Premji Invest and Board director at Kriya Therapeutics.
What does Curt Herberts invest in?
Curt Herberts invests in Biotech.
Where did Curt Herberts go to school?
Curt Herberts studied at Stanford University (BA, Human Biology); Stanford University Graduate School of Business (Coursework); Stanford Law School (Coursework).

Same school

Shared employers